Wolfy plays a level made just for him in Super Mario Maker 2.

Nintendo gamer Manx Ninja Pig recreates Goopy Le Grande's boss fight in Mario Maker 2.

GLP-1 drugs could lead to cost savings for workers and their employers by reducing employee sick leave, a new economic study finds. Researchers found that patients who used the drugs, sold under brand ...

(NEXSTAR) – Insurance coverage just changed for as many as 56 million Americans when it comes to the popular GLP-1 medications used to promote weight loss. Medicare announced it is offering certain ...

America is slimming down — one shot at a time. The number of US adults turning to blockbuster GLP-1 drugs like Ozempic and Wegovy for weight loss has hit a record high, nearly quadrupling in just two ...

Novo Nordisk (NYSE:NVO) stock is down 1% at $49.14, after the drugmaker filed a lawsuit against rival Eli Lilly (LLY), citing misleading advertising for its GLP-1 drugs. The company said it wants ...

Novo Nordisk sued rival drugmaker Eli Lilly, alleging false advertising claims about relative weight-loss drug performance. (Reuters via NBC News) GLP-1 drug use surged from 2017 to 2022, jumping 230% ...

Carley is a writer, editor and social media professional. Before starting at Forbes Health, she wrote for Sleepopolis and interned at PBS and Nickelodeon. She's a certified sleep science coach and ...

Brandon Chargoy, 31, has struggled with his weight most of his life, cycling through crash diets and fitness fads without much success. But after he was diagnosed with Type 2 diabetes, his doctor put ...

July 21 (UPI) --Novo Nordisk, the maker of Wegovy, filed a lawsuit on Tuesday against competitor Eli Lilly, alleging that its GLP-1 advertisements are misleading. Novo Nordisk claims that Eli Lilly is ...

The increasing rate of patients using GLP-1 medications is now boosting growth in Galderma's aesthetics portfolio, CEO Flemming Ørnskov told CNBC on Thursday. About 10% of U.S. adults now report ...

Novo Nordisk sued Eli Lilly on July 21 over what Novo said is false and misleading advertising comparing the effectiveness of the drug companies' respective injectable weight-loss medicines. The ...